Description: Enfusion Inc. offers software-as-a-service for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.
Home Page: www.enfusion.com
ENFN Technical Analysis
125 South Clark Street
Chicago,
IL
60603
United States
Phone:
312 253 9800
Officers
| Name | Title |
|---|---|
| Mr. Oleg Movchan | Interim CEO & Director |
| Mr. Stephen Malherbe | Managing Partner |
| Mr. Stephen P. Dorton | Chief Financial Officer |
| Mr. Michael Berry | Chief Operating Officer |
| Mr. Daniel Groman | Chief Technology Officer |
| Mr. Brian Murphy | Investor |
| Ms. Lorelei M. Skillman | Chief Marketing & Communications Officer |
| Ms. Bronwen Bastone | Chief People Officer |
| Mr. Kabir Kohli | MD of Managed Services Solutioning & Global Head of Client Services |
| Mr. Joseph Defeo | Global Head of Managed Services Production |
Exchange: NYSE
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 67.1141 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 10.7775 |
| Price-to-Sales TTM: | 4.533 |
| IPO Date: | 2021-10-21 |
| Fiscal Year End: | December |
| Full Time Employees: | 892 |